2V8-10296-50635
3 vaccinations
4 coded responses
28 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 727 / AR
- Registered
- 2021-07-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-22
Dose 1 — Pfizer-BioNTech
-
2021-07-29
Registered in v-safe
- 2021-07-29
- 2021-08-05
-
2021-08-12
Dose 2 — Pfizer-BioNTech
- 2021-08-12
- 2021-08-15
-
2021-08-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
- 2021-09-23
- 2021-11-11
-
2022-02-08
Dose 3 — Pfizer-BioNTech
- 2022-02-10
-
2022-02-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Fatigue or tirednessAdult check-in
- 2022-02-11
- 2022-02-12
-
2022-02-13
Survey response — days 1–6 daily, dose 3MedDRA: Throat irritation — Feeling: GoodFree text: Scratchy throatMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-02-15
- 2022-02-22
-
2022-03-08
Survey response — day 28, dose 3MedDRA: Galactostasis, Mastitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Mastitis/clogged milk ducts.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-08
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-10
- 2022-03-15
- 2022-03-22
-
2022-05-12
Survey response — 3 months, dose 3MedDRA: Diarrhoea, Gastrointestinal disorder — Feeling: GoodFree text: 2 week period of unexplained diarrhea/stomach issues.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-09
-
2023-02-10
Survey response — 12 months, dose 3MedDRA: Abdominal pain upper, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-02-10
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2023-02-13
- 2023-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-22 | Pfizer-BioNTech | No |
| 2 | 2021-08-12 | Pfizer-BioNTech | No |
| 3 | 2022-02-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-08 | Unsuccessful | |
| 2023-02-10 | Unsuccessful |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Scratchy throat
Release 11 — day 28, dose 3
Symptoms: Mastitis/clogged milk ducts.
Release 11 — 3 months, dose 3
Symptoms: 2 week period of unexplained diarrhea/stomach issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Galactostasis | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Mastitis | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release